We are live on ! Find out more
CCM

Concord Medical Services

4 hedge funds and large institutions have $608K invested in Concord Medical Services in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.04%0.04% (-0%)

9% less capital invested

Capital invested by funds: $666K → $608K (-$58K)

20% less funds holding

Funds holding: 54 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

CCM Hedge Fund Activity: Q2 2020 in Review

4 of the 4,887 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q2 2020, worth a combined $608K — down 8.7% from $666K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CCM and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $974. The largest seller was UBS Group, exiting entirely with an estimated $6K sold.

  • 4 institutional investors held Concord Medical Services (CCM) as of Q2 2020, down from 5 in Q1 2020.
  • Funds reported $608K of Concord Medical Services stock for Q2 2020, down 8.7% quarter-over-quarter.
  • 0 funds opened new Concord Medical Services positions in Q2 2020 and 1 closed out, a net change of -1 holder.
  • The largest Concord Medical Services buyer in Q2 2020 was Renaissance Technologies, an estimated $974 added.
  • The largest Concord Medical Services seller in Q2 2020 was UBS Group, an estimated $6K sold.

Based on aggregated 13F filings for Q2 2020.